New issue of Nordic Life Science Review

Alvotech has announced key senior leadership changes following a planned succession process.

Three researchers at Umeå University and one at the Swedish University of Agricultural Sciences (SLU) have been granted funding through Umeå Biotech Incubator’s (UBI) call “Pre‑Incubator Funding for Critical Experiments in Life Science.”

The company has signed an agreement with Dexcel Pharma USA, to divest the full rights to Zubsolv (buprenorphine/naloxone) sublingual tablet CIII, for the treatment of opioid use disorder, in the US.

The impact of heat due to climate change is becoming increasingly evident even in the Nordic countries. Heat is a significant cause of mortality among vulnerable groups and risks are further amplified by exposure to air pollution. It is thus crucial that cities be adapted to mitigate this phenomenon and adaptations made must benefit everyone, regardless of socioeconomic status.